Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

427 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Professional-patient discrepancies in assessing lung cancer radiotherapy symptoms: An international multicentre study.
Aguado-Barrera ME, Lopez-Pleguezuelos C, Gómez-Caamaño A, Calvo-Crespo P, Taboada-Valladares B, Azria D, Boisselier P, Briers E, Chan C, Chang-Claude J, Coedo-Costa C, Crujeiras-González A, Cuaron JJ, Defraene G, Elliott RM, Faivre-Finn C, Franceschini M, Fuentes-Rios O, Galego-Carro J, Gutiérrez-Enríquez S, Heumann P, Higginson DS, Johnson K, Lambrecht M, Lang P, Lievens Y, Mollà M, Ramos M, Rancati T, Rattay T, Rimner A, Rosenstein BS, Sangalli C, Seibold P, Sperk E, Stobart H, Symonds P, Talbot CJ, Vandecasteele K, Veldeman L, Ward T, Webb A, Woolf D, de Ruysscher D, West CML, Vega A; REQUITE Consortium. Aguado-Barrera ME, et al. Among authors: molla m. Lung Cancer. 2024 Dec 27;199:108072. doi: 10.1016/j.lungcan.2024.108072. Online ahead of print. Lung Cancer. 2024. PMID: 39740425
Feasibility and potential clinical benefit of dose de-escalation in stereotactic ablative radiotherapy for lung cancer lesions with ground glass opacities.
Cases C, Mollà M, Sánchez M, Benegas M, Ballestero M, Serrano-Rueda S, Antelo G, Gomà C. Cases C, et al. Among authors: molla m. Phys Imaging Radiat Oncol. 2024 Nov 29;32:100681. doi: 10.1016/j.phro.2024.100681. eCollection 2024 Oct. Phys Imaging Radiat Oncol. 2024. PMID: 39717187 Free PMC article.
Identifying predictors of treatment response and molecular changes induced by neoadjuvant chemotherapy and endocrine therapy in hormone receptor-positive/HER2-negative breast cancer: the NEOENDO translational study.
Schettini F, Brasó-Maristany F, Pascual T, Lorman-Carbó N, Nucera S, Bergamino M, Galván P, Conte B, Seguí E, García Fructuoso I, Gómez Bravo R, Rodríguez AB, Martínez-Sáez O, Chic N, Vidal M, Adamo B, González-Farre B, Sanfeliu E, Cebrecos I, Mensión E, Oses G, Locci M, Mollà M, Ganau S, Jares P, Vidal-Sicart S, Muñoz M, Prat A. Schettini F, et al. Among authors: molla m. ESMO Open. 2024 Dec;9(12):103989. doi: 10.1016/j.esmoop.2024.103989. Epub 2024 Nov 27. ESMO Open. 2024. PMID: 39608304 Free PMC article.
Genomic epidemiology of early SARS-CoV-2 transmission dynamics in Bangladesh.
Carnegie L, McCrone JT, du Plessis L, Hasan M, Ali MZ, Begum R, Hassan MZ, Islam S, Rahman MH, Uddin ASM, Sarker MS, Das T, Hossain M, Khan M, Razu MH, Akram A, Arina S, Hoque E, Molla MMA, Nafisaa T, Angra P, Rambaut A, Pullan ST, Osman KL, Hoque MA, Biswas P, Flora MS, Raghwani J, Fournié G, Samad MA, Hill SC. Carnegie L, et al. Among authors: molla mma. Virol J. 2024 Nov 13;21(1):291. doi: 10.1186/s12985-024-02560-2. Virol J. 2024. PMID: 39538264 Free PMC article.
Predicting Additional Metastases in Axillary Lymph Node Dissection After Neoadjuvant Chemotherapy: Ratio of Positive/Total Sentinel Nodes.
Cebrecos I, Torras I, Castillo H, Pumarola C, Ganau S, Sitges C, Vidal-Sicart S, Schettini F, Sanfeliu E, Loinaz I, Garcia M, Oses G, Molla M, Vidal M, Mension E. Cebrecos I, et al. Among authors: molla m. Cancers (Basel). 2024 Oct 29;16(21):3638. doi: 10.3390/cancers16213638. Cancers (Basel). 2024. PMID: 39518078 Free PMC article.
427 results